Zeuron

zeuron.ai is a deep tech startup focused on developing AI-driven solutions to better understand and manage various health conditions. Our first product, ReLive, is a Digital Therapeutics platform that assesses brain function and biomechanics, with plans to add blood-based assessments down the line. 

Initially focusing on diabetes and burnout, we believe ReLive has the potential to help over 70 million people in India, and over 500 million people worldwide who suffer from diabetes. Our long-term goal is to expand our platform's capabilities to address neurodegenerative disorders such as Alzheimer's Disease, Parkinson's Disease, and ALS.